BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10420457)

  • 1. [Effects of sodium ethamsylate on anticoagulant and anti-aggregation activity of vascular endothelium in hemorrhagic fever patients with renal syndrome].
    Davidovich IM; Sirotin BZ; Parshina TA
    Ter Arkh; 1999; 71(6):49-53. PubMed ID: 10420457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet-vascular and red cell components of hemostasis in hemodialyzed patients suffering from sever hemorrhagic fever with renal syndrome].
    Davidovich IM; Parshina TA
    Ter Arkh; 1999; 71(11):29-31. PubMed ID: 10626330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative efficacy of tiklid and aspirin in patients with unstable angina].
    Rebrov AP; Voskoboĭ IV
    Ter Arkh; 2001; 73(12):25-9. PubMed ID: 11858103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Central hemodynamic disorders and rheological red blood cell properties in hemorrhagic fever patients with renal syndrome].
    Ibragimova LA
    Klin Med (Mosk); 2001; 79(5):36-9. PubMed ID: 11510183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effectiveness and specific action of antiaggregants in patients with unstable angina].
    Rebrov AP; Voskoboĭ IV
    Klin Med (Mosk); 2000; 78(7):32-6. PubMed ID: 10979639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Outcome of antibiotic therapy in patients with hemorrhagic fever with renal syndrome].
    Sidel'nikov IuN; Martynenko AIu
    Ter Arkh; 2001; 73(11):78-81. PubMed ID: 11806215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basal and stimulated plasma antidiuretic activity of patients with hemorrhagic fever with renal syndrome].
    Davidovich IM
    Ter Arkh; 1986; 58(8):53-5. PubMed ID: 2876534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The dicynone treatment of hemorrhagic fever with renal syndrome].
    Sirotin BZ; Davidovich IM; Fedorchenko IuL; Utkin VN
    Voen Med Zh; 1994 Aug; (8):41-2. PubMed ID: 7839645
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemostatic agent ethamsylate promotes platelet/leukocyte aggregate formation in a model of vascular injury.
    Hernandez MR; Alvarez-Guerra M; Escolar G; Chiavaroli C; Hannaert P; Garay RP
    Fundam Clin Pharmacol; 2004 Aug; 18(4):423-30. PubMed ID: 15312148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
    Islim IF; Bareford D; Beevers DG
    Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antithrombogenic activity of the vascular wall, hemostasis, and rheological characteristics of blood in patients with unstable angina pectoris and various types of hyperlipoproteinemia].
    Kirichuk VF; Voskoboĭ IV
    Ter Arkh; 2000; 72(12):47-50. PubMed ID: 11201832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet stereological study in patients with HFRS].
    Lu M; Xie Y; Zeng Q
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):123-4, 149. PubMed ID: 11938766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The biggest epidemic of hemorrhagic fever with renal syndrome in Croatia].
    Kuzman I; Puljiz I; Turcinov D; Markotić A; Turković B; Aleraj B; Andrić Z; Petković D; Tutek V; Herendić B; Iskra M; Pandak N; Misetić Z; Perić L; Jelaska D; Majetić-Sekovanić M; Ledina D; Misić-Majerus L; Radonić R
    Acta Med Croatica; 2003; 57(5):337-46. PubMed ID: 15011458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The changes and relation among platelet function, plasma heparin and anti-coagulation-III: activity in patients with hemorrhagic fever with renal syndrome].
    Wei L; Pan X; Yu Y; Lu Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):163-5. PubMed ID: 15619827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphology and aggregative properties of erythrocytes in patients with hemorrhagic fever with nephrotic syndrome].
    Davidovich IM
    Ter Arkh; 1989; 61(2):70-2. PubMed ID: 2567064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-diagnostic evaluation of changes in ATPase activity, lipid peroxidation and stability of red cell membranes in patients suffering from hemorrhagic fever with renal syndrome].
    Ibragimova LA; Fazlyeva RM
    Ter Arkh; 2000; 72(11):21-4. PubMed ID: 11270949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.